Worth reading
64In focus
Scored from 4 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
1814
¥ million (year-on-year increase in revenue)Wording
Definitive
How definitive the wording is.Contents of this document
Earnings presentationQ3 FY20264 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥12,181 million+17.5%
Operating profit¥855 million+18.9%
Ordinary income¥851 million+19.9%
Net income¥474 million+2.6%
Gross Profit Margin30.1%
Selling, general and administrative expenses¥2,810 million
Results for the three months of the current quarterNet sales of ¥4,896 million, with individual figures for operating profit and other items shown in the graphs and materials
Full-year earnings forecast
Net Sales
¥15,685 million
Operating profit
¥994 million
Ordinary income
¥1,006 million
Net income
¥628 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales77.7%
Operating profit86.0%
EBITDA84.4%
Ordinary income84.6%
Net income75.5%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Profit-increasing factors¥539 million
- Cost-increasing factors¥-323 million
- Cost-increasing factors¥-80 million
New initiatives
- Post-M&A PMI initiatives following the acquisition of MedMarge
- Improvements to the e-commerce platform and UI/UX
- Marketing initiatives using social media, LINE and other channels
Key KPIsA metric the company considers important as a management benchmark.
- Private-label sales ratio17.5%Year on year against the same period last year+2.4 percentage points year on year
- BtoB PB sales ratio45%
- Active customer count (UU)18,454 UU
- Average order value¥3.2 thousand
- PB sales¥218 millionYear on year against the same period last year+21.4%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
- Active customer count (UU)18,454 UU
- Average order value¥3.2 thousand
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥12,181 million (YoY +17.5%) |
| Operating profit | ¥855 million (YoY +18.9%) |
| Ordinary income | ¥851 million (YoY +19.9%) |
| Net income | ¥474 million (YoY +2.6%) |
| Gross Profit Margin | 30.1% |
| Selling, general and administrative expenses | ¥2,810 million |
| Results for the three months of the current quarter | Net sales of ¥4,896 million, with individual figures for operating profit and other items shown in the graphs and materials |
| Full-year earnings forecast | Net Sales ¥15,685 million / Operating profit ¥994 million / Ordinary income ¥1,006 million / Net income ¥628 million |
| Progress against full-year forecast | Net Sales 77.7% / Operating profit 86.0% / EBITDA 84.4% / Ordinary income 84.6% / Net income 75.5% |
| Breakdown of Factors Affecting the Change | Factors Profit-increasing factors / Amount ¥539 million, Factors Cost-increasing factors / Amount ¥-323 million, Factors Cost-increasing factors / Amount ¥-80 million |
| Key KPIs | Indicator name Private-label sales ratio / Value 17.5% / Year on year against the same period last year +2.4 percentage points year on year, Indicator name BtoB PB sales ratio / Value 45% / Year on year against the same period last year Not disclosed, Indicator name Active customer count (UU) / Value 18,454 UU / Year on year against the same period last year Not disclosed, Indicator name Average order value / Value ¥3.2 thousand / Year on year against the same period last year Not disclosed, Indicator name PB sales / Value ¥218 million / Year on year against the same period last year ¥21.4 million |
| Unit price and quantity metrics | Indicator name Active customer count (UU) / Value 18,454 UU, Indicator name Average order value / Value ¥3.2 thousand |
| New initiatives | Post-M&A PMI initiatives following the acquisition of MedMarge, Improvements to the e-commerce platform and UI/UX, Marketing initiatives using social media, LINE and other channels |
Items this document does not state (16)
Operating profit marginSelf-assessment against the planSegment resultsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The materials cite M&A, expansion of the BtoB and BtoC businesses, and increased private-label (PB) sales as factors behind the results. They also show operating profit increase and decrease factors, comprising ¥539 million in profit-increasing factors and ¥323 million and ¥80 million in cost-increasing factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.